What top creators are saying about Viking Therapeutics, Inc.(VKTX)
Biopharmaceutical company focused on metabolic and endocrine disorders.
5 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Viking Therapeutics, Inc. in the last 30 days yet.
Top creators covering Viking Therapeutics, Inc. (VKTX)
The 2 sources with the most insights about Viking Therapeutics, Inc. on Kazuha.
Latest insights about Viking Therapeutics, Inc. (VKTX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, April 6, 2026
Phase 2 data for VK2735 looks good, but Phase 3 results are long-dated (2027), making it a long-term play.
Monday, January 5, 2026
A bearish sentiment was expressed, with the speaker stating, 'I think Viking is kind of cooked, man,' implying its positive run may be over.
Wednesday, December 31, 2025
Mentioned as a liked small-cap biotech name that could be an M&A target, potentially leading to sharp stock price increases.
Thursday, October 2, 2025
Identified as a key player and a company 'to watch' for investors looking to gain exposure to the GLP-1 theme.
Friday, August 1, 2025
Faces potential headwinds as the speaker believes the weight-loss drug sector is 'over' due to struggles from market leader Novo Nordisk.
Monday, April 6, 2026
Phase 2 data for VK2735 looks good, but Phase 3 results are long-dated (2027), making it a long-term play.
Monday, January 5, 2026
A bearish sentiment was expressed, with the speaker stating, 'I think Viking is kind of cooked, man,' implying its positive run may be over.
Wednesday, December 31, 2025
Mentioned as a liked small-cap biotech name that could be an M&A target, potentially leading to sharp stock price increases.
Thursday, October 2, 2025
Identified as a key player and a company 'to watch' for investors looking to gain exposure to the GLP-1 theme.
Friday, August 1, 2025
Faces potential headwinds as the speaker believes the weight-loss drug sector is 'over' due to struggles from market leader Novo Nordisk.
Discussed alongside Viking Therapeutics, Inc. (VKTX)
Other assets that creators frequently mention in the same content as Viking Therapeutics, Inc..
Frequently asked
Which podcasters and creators cover Viking Therapeutics, Inc. (VKTX) the most?
The most active sources covering Viking Therapeutics, Inc. (VKTX) on Kazuha are @realmartinshkreli, RiskReversal Media. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Viking Therapeutics, Inc. (VKTX) are on Kazuha?
Kazuha has indexed 5 AI-extracted insights about Viking Therapeutics, Inc. (VKTX) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Viking Therapeutics, Inc. (VKTX)?
Creators covering Viking Therapeutics, Inc. (VKTX) most frequently also discuss NVO, NVDA, LLY, PFE, SRPT. See the "Discussed alongside" section above for full asset pages.